Global Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Regional Outlook and Forecast, 2024

List of Tables

The Global Inhalation Capsules Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.

Several factors contribute to the high prevalence of asthma in the U.S., including air pollution, allergens, tobacco smoke, and obesity. Urban areas, particularly in the Northeast and Midwest, have higher asthma rates due to higher air pollution and allergens. Consequently, the North America region generated USD 312.7 million revenue of the market in 2023. Moreover, the region has high healthcare spending, allowing patients better access to advanced treatment options, including inhalation capsules.

Technological advancements have resulted in the development of inhalation devices that are easier to use and more intuitive for patients. Features such as one-click mechanisms, ergonomic designs, and simplified instructions make inhalation devices more user-friendly, improving patient adherence and satisfaction. Advanced inhalation devices incorporate mechanisms to ensure precise and consistent medication dosing. Therefore, as these technological advancements evolve, the market is expected to expand further.

Additionally, as healthcare infrastructure improves and access to medical services increases, a growing demand for effective and convenient treatment options for respiratory diseases drives the demand for inhalation capsules. For example, in countries like China and India, where the healthcare industry is rapidly expanding, there is a significant increase in the prevalence of respiratory diseases due to factors such as air pollution and smoking. Hence, the substantial expansion of the healthcare industry globally has created a conducive environment for the growth of the market.

However, Inhalation capsules deliver medication directly to the lungs, but some amount of the drug may enter the bloodstream and cause systemic side effects. These side effects can include cardiovascular effects, changes in blood pressure, or alterations in metabolic parameters. Particularly with prolonged use or high doses, patients and medical professionals may be concerned about the potential for systemic adverse effects associated with inhalation therapies. Hence, these factors may hamper the market's growth.

Furthermore, the COVID-19 pandemic reshaping demand dynamics, supply chains, and healthcare delivery methods. With the heightened focus on respiratory health during the pandemic, there was an increased demand for medications delivered via inhalation capsules, driven by patients seeking to manage respiratory conditions such as asthma and COPD. Thus, the pandemic had an overall positive impact on the market.

By Type Analysis

Based on type, the market is characterized by gelatin capsules and hypromellose capsules. In 2023, the hypromellose capsules segment recorded a 38.2% revenue share in the market. Hypromellose capsules, also known as hydroxypropyl methylcellulose (HPMC) capsules, are gaining within the market. HPMC capsules offer several key benefits that make them well-suited for inhalation therapy. This versatility enables pharmaceutical companies to develop inhalation capsules containing various active pharmaceutical ingredients, catering to the specific needs of patients with different respiratory conditions.

By Application Analysis

On the basis of application, the market is classified into asthma treatment, COPD management, and others. The asthma treatment segment procured 48.5% revenue share in the market in 2023. Asthma treatment within the market encompasses a wide range of medications and delivery devices tailored to manage the symptoms and underlying inflammation associated with this chronic respiratory condition. Inhalation therapy is considered the cornerstone of asthma management because it delivers medications directly to the lungs, resulting in rapid onset of action, targeted treatment, and reduced systemic side effects.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe region held a 29.3% revenue share in the market in 2023. Europe is a leader in healthcare technology, leading to the development of advanced inhalation devices and formulations that drive market growth. Patients and healthcare professionals alike are well-informed regarding the advantages of inhalation therapy, which is propelling market expansion. Moreover, Europe has a favorable regulatory environment for developing and commercializing inhalation capsules, encouraging market growth.

Recent Strategies Deployed in the Market

Mar-2024: AstraZeneca Pharma India Limited, a subsidiary of AstraZeneca PLC, signed an agreement with Mankind Pharma Limited, a pharmaceutical company. Under this agreement, Mankind Pharma will exclusively distribute budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India.
Dec-2023: AstraZeneca PLC got approval for its inhalation aerosol from the Central Drugs Standard Control Organisation (CDSCO). The inhalation aerosol consists of a triple combination of budesonide (160 mcg), glycopyrrolate (9 mcg), and formoterol fumarate (4.8 mcg) and is prescribed for the treatment and maintenance of patients with chronic obstructive pulmonary disease (COPD).
May-2021: Vectura Group Plc expanded its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K. Through this expansion, the company aims to facilitate integration with capsule inhaler devices, such as Vectura's open inhale close (OIC) device and the lever-operated multi-dose inhaler (LOMI) device utilized in Hikma's generic Advair product.
Mar-2021: Chiesi USA, Inc., a subsidiary of Chiesi Farmaceutici S.p.A., unveiled its bronchitol (mannitol) inhalation powder. The product is a dry powder-inhaled mucoactive agent that is compact, discrete, and portable and does not necessitate any nebulization, refrigeration, or routine cleaning.
Nov-2020: Chiesi Farmaceutici S.p.A. came into a partnership with Kaia Health Software GmbH, a digital therapeutics company. Under this partnership, the companies will market the Kaia Health Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Rehabilitation app across Europe. Additionally, the partnership aims to provide patients with a digital therapeutic tool that facilitates COPD treatment outcomes by fostering behaviour change.

List of Key Companies Profiled

Cipla Limited
Novartis AG
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Lonza Group Ltd. (Capsugel)
Chiesi Farmaceutici S.p.A
Vectura Group Plc (Philip Morris International, Inc.)
Elpen S.A.
Healthcaps India Ltd.
Qualicaps Co., LTD. (Roquette Freres SA)

Global Inhalation Capsules Market Report Segmentation

By Type

Gelatin Capsules
Hypromellose Capsules

By Application

Asthma Treatment
COPD Management
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global Inhalation Capsules Market, by Type
- 1.4.2Global Inhalation Capsules Market, by Application
- 1.4.3Global Inhalation Capsules Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5.Global Inhalation Capsules Market by Type

5.1Global Gelatin Capsules Market by Region
5.2Global Hypromellose Capsules Market by Region

Chapter 6.Global Inhalation Capsules Market by Application

6.1Global Asthma Treatment Market by Region
6.2Global COPD Management Market by Region
6.3Global Others Market by Region

Chapter 7.Global Inhalation Capsules Market by Region

7.1North America Inhalation Capsules Market
- 7.1.1North America Inhalation Capsules Market by Type
  - 7.1.1.1North America Gelatin Capsules Market by Region
  - 7.1.1.2North America Hypromellose Capsules Market by Region
- 7.1.2North America Inhalation Capsules Market by Application
  - 7.1.2.1North America Asthma Treatment Market by Country
  - 7.1.2.2North America COPD Management Market by Country
  - 7.1.2.3North America Others Market by Country
- 7.1.3North America Inhalation Capsules Market by Country
  - 7.1.3.1US Inhalation Capsules Market
    - 7.1.3.1.1US Inhalation Capsules Market by Type
    - 7.1.3.1.2US Inhalation Capsules Market by Application
  - 7.1.3.2Canada Inhalation Capsules Market
    - 7.1.3.2.1Canada Inhalation Capsules Market by Type
    - 7.1.3.2.2Canada Inhalation Capsules Market by Application
  - 7.1.3.3Mexico Inhalation Capsules Market
    - 7.1.3.3.1Mexico Inhalation Capsules Market by Type
    - 7.1.3.3.2Mexico Inhalation Capsules Market by Application
  - 7.1.3.4Rest of North America Inhalation Capsules Market
    - 7.1.3.4.1Rest of North America Inhalation Capsules Market by Type
    - 7.1.3.4.2Rest of North America Inhalation Capsules Market by Application
7.2Europe Inhalation Capsules Market
- 7.2.1Europe Inhalation Capsules Market by Type
  - 7.2.1.1Europe Gelatin Capsules Market by Country
  - 7.2.1.2Europe Hypromellose Capsules Market by Country
- 7.2.2Europe Inhalation Capsules Market by Application
  - 7.2.2.1Europe Asthma Treatment Market by Country
  - 7.2.2.2Europe COPD Management Market by Country
  - 7.2.2.3Europe Others Market by Country
- 7.2.3Europe Inhalation Capsules Market by Country
  - 7.2.3.1Germany Inhalation Capsules Market
    - 7.2.3.1.1Germany Inhalation Capsules Market by Type
    - 7.2.3.1.2Germany Inhalation Capsules Market by Application
  - 7.2.3.2UK Inhalation Capsules Market
    - 7.2.3.2.1UK Inhalation Capsules Market by Type
    - 7.2.3.2.2UK Inhalation Capsules Market by Application
  - 7.2.3.3France Inhalation Capsules Market
    - 7.2.3.3.1France Inhalation Capsules Market by Type
    - 7.2.3.3.2France Inhalation Capsules Market by Application
  - 7.2.3.4Russia Inhalation Capsules Market
    - 7.2.3.4.1Russia Inhalation Capsules Market by Type
    - 7.2.3.4.2Russia Inhalation Capsules Market by Application
  - 7.2.3.5Spain Inhalation Capsules Market
    - 7.2.3.5.1Spain Inhalation Capsules Market by Type
    - 7.2.3.5.2Spain Inhalation Capsules Market by Application
  - 7.2.3.6Italy Inhalation Capsules Market
    - 7.2.3.6.1Italy Inhalation Capsules Market by Type
    - 7.2.3.6.2Italy Inhalation Capsules Market by Application
  - 7.2.3.7Rest of Europe Inhalation Capsules Market
    - 7.2.3.7.1Rest of Europe Inhalation Capsules Market by Type
    - 7.2.3.7.2Rest of Europe Inhalation Capsules Market by Application
7.3Asia Pacific Inhalation Capsules Market
- 7.3.1Asia Pacific Inhalation Capsules Market by Type
  - 7.3.1.1Asia Pacific Gelatin Capsules Market by Country
  - 7.3.1.2Asia Pacific Hypromellose Capsules Market by Country
- 7.3.2Asia Pacific Inhalation Capsules Market by Application
  - 7.3.2.1Asia Pacific Asthma Treatment Market by Country
  - 7.3.2.2Asia Pacific COPD Management Market by Country
  - 7.3.2.3Asia Pacific Others Market by Country
- 7.3.3Asia Pacific Inhalation Capsules Market by Country
  - 7.3.3.1China Inhalation Capsules Market
    - 7.3.3.1.1China Inhalation Capsules Market by Type
    - 7.3.3.1.2China Inhalation Capsules Market by Application
  - 7.3.3.2Japan Inhalation Capsules Market
    - 7.3.3.2.1Japan Inhalation Capsules Market by Type
    - 7.3.3.2.2Japan Inhalation Capsules Market by Application
  - 7.3.3.3India Inhalation Capsules Market
    - 7.3.3.3.1India Inhalation Capsules Market by Type
    - 7.3.3.3.2India Inhalation Capsules Market by Application
  - 7.3.3.4South Korea Inhalation Capsules Market
    - 7.3.3.4.1South Korea Inhalation Capsules Market by Type
    - 7.3.3.4.2South Korea Inhalation Capsules Market by Application
  - 7.3.3.5Australia Inhalation Capsules Market
    - 7.3.3.5.1Australia Inhalation Capsules Market by Type
    - 7.3.3.5.2Australia Inhalation Capsules Market by Application
  - 7.3.3.6Malaysia Inhalation Capsules Market
    - 7.3.3.6.1Malaysia Inhalation Capsules Market by Type
    - 7.3.3.6.2Malaysia Inhalation Capsules Market by Application
  - 7.3.3.7Rest of Asia Pacific Inhalation Capsules Market
    - 7.3.3.7.1Rest of Asia Pacific Inhalation Capsules Market by Type
    - 7.3.3.7.2Rest of Asia Pacific Inhalation Capsules Market by Application
7.4LAMEA Inhalation Capsules Market
- 7.4.1LAMEA Inhalation Capsules Market by Type
  - 7.4.1.1LAMEA Gelatin Capsules Market by Country
  - 7.4.1.2LAMEA Hypromellose Capsules Market by Country
- 7.4.2LAMEA Inhalation Capsules Market by Application
  - 7.4.2.1LAMEA Asthma Treatment Market by Country
  - 7.4.2.2LAMEA COPD Management Market by Country
  - 7.4.2.3LAMEA Others Market by Country
- 7.4.3LAMEA Inhalation Capsules Market by Country
  - 7.4.3.1Brazil Inhalation Capsules Market
    - 7.4.3.1.1Brazil Inhalation Capsules Market by Type
    - 7.4.3.1.2Brazil Inhalation Capsules Market by Application
  - 7.4.3.2Argentina Inhalation Capsules Market
    - 7.4.3.2.1Argentina Inhalation Capsules Market by Type
    - 7.4.3.2.2Argentina Inhalation Capsules Market by Application
  - 7.4.3.3UAE Inhalation Capsules Market
    - 7.4.3.3.1UAE Inhalation Capsules Market by Type
    - 7.4.3.3.2UAE Inhalation Capsules Market by Application
  - 7.4.3.4Saudi Arabia Inhalation Capsules Market
    - 7.4.3.4.1Saudi Arabia Inhalation Capsules Market by Type
    - 7.4.3.4.2Saudi Arabia Inhalation Capsules Market by Application
  - 7.4.3.5South Africa Inhalation Capsules Market
    - 7.4.3.5.1South Africa Inhalation Capsules Market by Type
    - 7.4.3.5.2South Africa Inhalation Capsules Market by Application
  - 7.4.3.6Nigeria Inhalation Capsules Market
    - 7.4.3.6.1Nigeria Inhalation Capsules Market by Type
    - 7.4.3.6.2Nigeria Inhalation Capsules Market by Application
  - 7.4.3.7Rest of LAMEA Inhalation Capsules Market
    - 7.4.3.7.1Rest of LAMEA Inhalation Capsules Market by Type
    - 7.4.3.7.2Rest of LAMEA Inhalation Capsules Market by Application

Chapter 8.Company Profiles

8.1Cipla Limited
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Novartis AG
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Trials and Approvals:
- 8.2.6SWOT Analysis
8.3AstraZeneca PLC
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Partnerships, Collaborations, and Agreements:
  - 8.3.5.2Trials and Approvals:
- 8.3.6SWOT Analysis
8.4Boehringer Ingelheim International GmbH
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional & Segmental Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
8.5Lonza Group Ltd. (Capsugel)
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
8.6Chiesi Farmaceutici S.p.A
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
  - 8.6.2.1Partnerships, Collaborations, and Agreements:
  - 8.6.2.2Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
8.7Vectura Group plc (Philip Morris International, Inc.)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
  - 8.7.5.1Partnerships, Collaborations, and Agreements:
  - 8.7.5.2Geographical Expansions:
- 8.7.6SWOT Analysis
8.8Elpen S.A.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
8.9Healthcaps India Ltd.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
8.10.Qualicaps Co., LTD. (Roquette Freres SA)
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

Chapter 9.Winning Imperatives of Inhalation Capsules Market

LIST OF TABLES

TABLE 1Global Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 2Global Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 3Global Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 4Global Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 5Global Gelatin Capsules Market by Region, 2020 - 2023, USD Million
TABLE 6Global Gelatin Capsules Market by Region, 2024 - 2031, USD Million
TABLE 7Global Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
TABLE 8Global Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
TABLE 9Global Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 10Global Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 11Global Asthma Treatment Market by Region, 2020 - 2023, USD Million
TABLE 12Global Asthma Treatment Market by Region, 2024 - 2031, USD Million
TABLE 13Global COPD Management Market by Region, 2020 - 2023, USD Million
TABLE 14Global COPD Management Market by Region, 2024 - 2031, USD Million
TABLE 15Global Others Market by Region, 2020 - 2023, USD Million
TABLE 16Global Others Market by Region, 2024 - 2031, USD Million
TABLE 17Global Inhalation Capsules Market by Region, 2020 - 2023, USD Million
TABLE 18Global Inhalation Capsules Market by Region, 2024 - 2031, USD Million
TABLE 19North America Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 20North America Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 21North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 22North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 23North America Gelatin Capsules Market by Region, 2020 - 2023, USD Million
TABLE 24North America Gelatin Capsules Market by Region, 2024 - 2031, USD Million
TABLE 25North America Hypromellose Capsules Market by Region, 2020 - 2023, USD Million
TABLE 26North America Hypromellose Capsules Market by Region, 2024 - 2031, USD Million
TABLE 27North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 28North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 29North America Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 30North America Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 31North America COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 32North America COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 33North America Others Market by Country, 2020 - 2023, USD Million
TABLE 34North America Others Market by Country, 2024 - 2031, USD Million
TABLE 35North America Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 36North America Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 37US Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 38US Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 39US Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 40US Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 41US Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 42US Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 43Canada Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 44Canada Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 45Canada Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 46Canada Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 47Canada Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 48Canada Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 49Mexico Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 50Mexico Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 51Mexico Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 52Mexico Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 53Mexico Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 54Mexico Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 55Rest of North America Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 56Rest of North America Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 57Rest of North America Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 58Rest of North America Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 59Rest of North America Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 60Rest of North America Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 61Europe Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 62Europe Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 63Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 64Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 65Europe Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 66Europe Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 67Europe Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 68Europe Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 69Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 70Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 71Europe Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 72Europe Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 73Europe COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 74Europe COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 75Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 76Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 77Europe Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 78Europe Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 79Germany Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 80Germany Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 81Germany Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 82Germany Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 83Germany Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 84Germany Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 85UK Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 86UK Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 87UK Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 88UK Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 89UK Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 90UK Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 91France Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 92France Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 93France Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 94France Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 95France Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 96France Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 97Russia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 98Russia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 99Russia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 100Russia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 101Russia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 102Russia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 103Spain Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 104Spain Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 105Spain Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 106Spain Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 107Spain Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 108Spain Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 109Italy Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 110Italy Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 111Italy Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 112Italy Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 113Italy Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 114Italy Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 115Rest of Europe Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 116Rest of Europe Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 117Rest of Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 118Rest of Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 119Rest of Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 120Rest of Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 121Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 122Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 123Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 124Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 125Asia Pacific Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 126Asia Pacific Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 127Asia Pacific Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 128Asia Pacific Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 129Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 130Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 131Asia Pacific Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 132Asia Pacific Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 133Asia Pacific COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 134Asia Pacific COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 135Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 136Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 137Asia Pacific Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 138Asia Pacific Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 139China Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 140China Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 141China Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 142China Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 143China Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 144China Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 145Japan Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 146Japan Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 147Japan Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 148Japan Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 149Japan Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 150Japan Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 151India Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 152India Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 153India Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 154India Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 155India Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 156India Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 157South Korea Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 158South Korea Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 159South Korea Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 160South Korea Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 161South Korea Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 162South Korea Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 163Australia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 164Australia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 165Australia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 166Australia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 167Australia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 168Australia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 169Malaysia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 170Malaysia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 171Malaysia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 172Malaysia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 173Malaysia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 174Malaysia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 175Rest of Asia Pacific Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 176Rest of Asia Pacific Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 177Rest of Asia Pacific Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 178Rest of Asia Pacific Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 179Rest of Asia Pacific Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 180Rest of Asia Pacific Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 181LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 182LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 183LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 184LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 185LAMEA Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 186LAMEA Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 187LAMEA Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 188LAMEA Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 189LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 190LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 191LAMEA Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 192LAMEA Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 193LAMEA COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 194LAMEA COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 195LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 196LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 197LAMEA Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 198LAMEA Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 199Brazil Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 200Brazil Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 201Brazil Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 202Brazil Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 203Brazil Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 204Brazil Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 205Argentina Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 206Argentina Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 207Argentina Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 208Argentina Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 209Argentina Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 210Argentina Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 211UAE Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 212UAE Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 213UAE Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 214UAE Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 215UAE Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 216UAE Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 217Saudi Arabia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 218Saudi Arabia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 219Saudi Arabia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 220Saudi Arabia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 221Saudi Arabia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 222Saudi Arabia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 223South Africa Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 224South Africa Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 225South Africa Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 226South Africa Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 227South Africa Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 228South Africa Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 229Nigeria Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 230Nigeria Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 231Nigeria Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 232Nigeria Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 233Nigeria Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 234Nigeria Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 235Rest of LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 236Rest of LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 237Rest of LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 238Rest of LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 239Rest of LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 240Rest of LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 241Key Information - Cipla Limited
TABLE 242Key Information - Novartis AG
TABLE 243Key Information - AstraZeneca PLC
TABLE 244Key Information - Boehringer Ingelheim International GmbH
TABLE 245Key Information -Lonza Group Ltd.
TABLE 246Key Information - Chiesi Farmaceutici S.p.A
TABLE 247Key Information - Vectura Group plc
TABLE 248Key Information - Elpen S.A.
TABLE 249Key Information - Healthcaps India Ltd.
TABLE 250Key Information - Qualicaps Co., LTD.

Global Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Regional Outlook and Forecast, 2024 - 2031

Description

Table of Contents